Diamond-like carbon (DLC) film deposited by plasma enhanced chemical vapor deposition (PECVD) methods has a very smooth and inert surface, and is believed to be one of the excellent bio-compatible coating materials for the medical devices [1] [2] [3] [4] [5] [6] [7] [8] [9] . Their studies for clarifying the deposition mechanisms [10] [11] [12] and chemical structural analysis of DLC films have been extensively pursued [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Plasma surface treatment technology has a possibility to improve the adhesion property and bio-compatibility of DLC film by the introduction of polar functional groups onto the surface. Dr. Nakatani's group has been developing a DLC film surface, of which zeta potential can be controlled by plasma surface treatment technology, and realized further improvement in bio-compatibility.
As for the control of zeta potentials of the DLC surface, they have studied the methods to introduce anionic and cationic functional groups to the DLC surface and succeeded in varying the potential from lower negative value to positive value [23] . In addition, they found that the zeta potential related to the compatibility with blood and the tissue cells [24, 25] . That is, the appropriate zeta potential or the composition ratios of anionic group to cationic group on the top surface bring about the excellent bio-compatibility of DLC surface (named as biomimetic DLC) [26] [27] [28] [29] [30] .
Study of plasma processing also gave new results. In the results, the most innovative finding is high tenacity and adhesion property by a gradient structure for the DLC film [21] . Thus, they have succeeded in application of the DLC film to coronary stent (named as DLC nano-coated stent). The superior adhesion onto stent base material and its tenacity result in no cracks of the DLC film on a stent when the stent is expanded in blood vessel. This improvement was achieved by increasing Si concentration during the doping in DLC film deposition process [21] . The results of their studies were presented in current scientific conferences.
The commercial production of the DLC nano-coated stent has started in Japan and its clinical evaluation has been carried out in Europe after European CE marking was approved in 2008.
In addition, a new drug eluting coronary stent (DES) is now being created by applying the plasma techniques to DLC coated stent [21, 31] . The treatment can enhance its adhesive property to the matrix layer on the stent as drug carrier composed of bio-degradable polymer and depress any allergic action after the disappearance of the layer. The efficacy of new DLC coating has been widely recognized in domestic and international medical market, and as for DES, the verification and efficacy of drug eluting stent is under evaluation in Good-Laboratory-Practice animal study.
To develop the surface of high performance coronary stent in the next generation, it is necessary to verify the importance of biomimetic DLC film. As described above, Dr. Nakatani's group has conducted fundamental research on fabrication and functionality of DLC film surface aiming at medical devices.
Over 30 papers have been published in this field. The studies mentioned earlier were remarkably excellent and innovative and gave an impact on both science and engineering fields, resulting in providing a successful model case in medical interdisciplinary field. This success was achieved
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